Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGSNet product sales of FILSPARI ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on ...

Pazopanib-associated ALT elevations have a robust, confirmed association with HFE polymorphisms, suggesting that some of these changes may be linked to regulation of hepatic iron deposition.

Hepatotoxicity is damage or injury to the liver as a result of damaging or destructive agents such as drugs or industrial chemicals which are termed hepatotoxins. This study reveals that ...

Acute and chronic treatment for hepatic encephalopathy acquired from Mallinckrodt Pharmaceuticals in September 2024Extended pre-clinical, ...

Given the potential for synergistic hepatotoxicity with other medications (eg, acetaminophen), alcohol9 10 and herbal supplements, the public health community should focus intense scrutiny on possible ...

The integration of cytokines into stem cell and organoid research has significantly advanced drug discovery by enabling more ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Shannin Desroches fought for a diagnosis after being dismissed. Now she tells PEOPLE that she's been given a 5% chance of ...

Nucleoside analogs are transformative in cancer and antiviral therapies, offering new avenues for treatment despite ...

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...